Literature DB >> 24855172

Improvement of electrophysiological neuropathy after islet transplantation for type 1 diabetes: a 5-year prospective study.

Marie-Christine Vantyghem1, Delphine Quintin2, Robert Caiazzo3, Clara Leroy2, Violeta Raverdy3, François Cassim4, François Glowacki5, Thomas Hubert6, Valery Gmyr6, Christian Noel5, Julie Kerr-Conte6, François Pattou3.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24855172     DOI： 10.2337/dc14-0320

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  9 in total

Review 1.  Immunological Monitoring in Beta Cell Replacement: Towards a Pathophysiology-Guided Implementation of Biomarkers.

Authors:  Fanny Buron; Sophie Reffet; Lionel Badet; Emmanuel Morelon; Olivier Thaunat
Journal:  Curr Diab Rep       Date:  2021-04-25       Impact factor: 4.810

Review 2.  Advances in β-cell replacement therapy for the treatment of type 1 diabetes.

Authors:  Marie-Christine Vantyghem; Eelco J P de Koning; François Pattou; Michael R Rickels
Journal:  Lancet       Date:  2019-09-15       Impact factor: 79.321

Review 3.  Pancreatic Islet Transplantation in Humans: Recent Progress and Future Directions.

Authors:  Michael R Rickels; R Paul Robertson
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

Review 4.  Type 1 diabetes and engineering enhanced islet transplantation.

Authors:  Abiramy Jeyagaran; Chuan-En Lu; Aline Zbinden; Andreas L Birkenfeld; Sara Y Brucker; Shannon L Layland
Journal:  Adv Drug Deliv Rev       Date:  2022-08-21       Impact factor: 17.873

Review 5.  Felix dies natalis, insulin… ceterum autem censeo "beta is better".

Authors:  Lorenzo Piemonti
Journal:  Acta Diabetol       Date:  2021-05-23       Impact factor: 4.280

6.  Examination of the Igls Criteria for Defining Functional Outcomes of β-cell Replacement Therapy: IPITA Symposium Report.

Authors:  Cyril P Landstra; Axel Andres; Mikael Chetboun; Caterina Conte; Yvonne Kelly; Thierry Berney; Eelco J P de Koning; Lorenzo Piemonti; Peter G Stock; François Pattou; Marie-Christine Vantyghem; Melena D Bellin; Michael R Rickels
Journal:  J Clin Endocrinol Metab       Date:  2021-09-27       Impact factor: 6.134

7.  Type 2 diabetes mellitus and microvascular complications 1 year after Roux-en-Y gastric bypass: a case-control study.

Authors:  Alexander D Miras; Ling Ling Chuah; Nofal Khalil; Alessia Nicotra; Amoolya Vusirikala; Najah Baqai; Christopher Graham; Saranya Ravindra; Gerassimos Lascaratos; Nick Oliver; Carel W le Roux
Journal:  Diabetologia       Date:  2015-04-18       Impact factor: 10.122

Review 8.  Single-donor islet transplantation in type 1 diabetes: patient selection and special considerations.

Authors:  Jacob A Tatum; Max O Meneveau; Kenneth L Brayman
Journal:  Diabetes Metab Syndr Obes       Date:  2017-02-28       Impact factor: 3.168

Review 9.  Regenerative Therapy of Type 1 Diabetes Mellitus: From Pancreatic Islet Transplantation to Mesenchymal Stem Cells.

Authors:  Nadine E Rekittke; Meidjie Ang; Divya Rawat; Rahul Khatri; Thomas Linn
Journal:  Stem Cells Int       Date:  2016-03-07       Impact factor: 5.443
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.